Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells | Scientific Reports
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA | ACS Pharmacology & Translational Science
Sequencing electropherogram of KRAS exon 2. (A) Wild-type. (B) G12D... | Download Scientific Diagram
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
The current understanding of KRAS protein structure and dynamics - ScienceDirect
Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG‑510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by
Drugging KRAS: current perspectives and state-of-art review | Journal of Hematology & Oncology | Full Text
Example (case 6, Table 3) of DNA sequence (anti-sense) of KRAS mutation... | Download Scientific Diagram
Sequence analysis of KRAS gene mutation in codon 61 in two... | Download Scientific Diagram
KRAS G12C Reference Standard, 50% 1 ug
An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants | bioRxiv
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Acquired/intratumoral mutation of KRAS during metastatic progression of colorectal carcinogenesis
Detection of KRAS mutation in a colorectal cancer sample using DNA... | Download Scientific Diagram
KRAS mutation analysis (direct sequencing) of codon 12 of exon 2. (A)... | Download Scientific Diagram
Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR | BMJ Open
sequencing electropherogram of KRAS gene exon 1: (A) g12D mutation; (B)... | Download Scientific Diagram
KRAS Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific | Nature Communications
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
